Differential prognostic impact of cytopenic phenotype in prefibrotic vs overt primary myelofibrosis

被引：17
|
作者：
Coltro, Giacomo [1 ,2 ]
Mannelli, Francesco [1 ,2 ]
Loscocco, Giuseppe Gaetano [1 ,2 ]
Mannarelli, Carmela [1 ,2 ]
Rotunno, Giada [1 ,2 ]
Maccari, Chiara [1 ,2 ]
Pancani, Fabiana [1 ,2 ]
Atanasio, Alessandro [1 ,2 ]
Vannucchi, Alessandro Maria [1 ,2 ]
Guglielmelli, Paola [1 ,2 ]
机构：
[1] Univ Florence, Dept Clin & Expt Med, Florence, Italy
[2] Azienda Osped Univ Careggi, Ctr Res & Innovat Myeloproliferat Neoplasms CRIMM, Florence, Italy
来源：
BLOOD CANCER JOURNAL | 2022年 / 12卷 / 08期
关键词：
INTERNATIONAL WORKING GROUP; AGNOGENIC MYELOID METAPLASIA; SURVIVAL; SYSTEM; AGE;
D O I：
10.1038/s41408-022-00713-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页数：7
相关论文
共 13 条
  • [1] Presentation and outcome of patients with 2016 WHO diagnosis of prefibrotic and overt primary myelofibrosis
    Guglielmelli, Paola
    Pacilli, Annalisa
    Rotunno, Giada
    Rumi, Elisa
    Rosti, Vittorio
    Delaini, Federica
    Maffioli, Margherita
    Fanelli, Tiziana
    Pancrazzi, Alessandro
    Pietra, Daniela
    Salmoiraghi, Silvia
    Mannarelli, Carmela
    Franci, Annalisa
    Paoli, Chiara
    Rambaldi, Alessandro
    Passamonti, Francesco
    Barosi, Giovanni
    Barbui, Tiziano
    Cazzola, Mario
    Vannucchi, Alessandro M.
    BLOOD, 2017, 129 (24) : 3227 - 3236
  • [2] Cytopenic overt primary myelofibrosis at presentation: Analysis of outcomes in the prospective, real-world ERNEST-2 registry
    Guglielmelli, Paola
    Ghirardi, Arianna
    Carobbio, Alessandra
    Masciulli, Arianna
    Morrone, Lucrezia
    Mora, Barbara
    Rumi, Elisa
    Triguero, Ana
    Finazzi, Maria C.
    Pettersson, Helna
    Boldrini, Valentina
    Vanni, Daniele
    Rambaldi, Alessandro
    Passamonti, Francesco
    Alvarez-Larran, Alberto
    Andreasson, Bjorn
    Vannucchi, Alessandro M.
    Barbui, Tiziano
    HEMASPHERE, 2025, 9 (02):
  • [3] Clinical features and next-generation sequencing landscape of essential thrombocythemia, prefibrotic primary myelofibrosis, and overt fibrotic primary myelofibrosis: a Chinese monocentric retrospective study
    Zhang, Lan
    Ye, Xingnong
    Luo, Shuna
    Xu, Xiaofei
    Wang, Shengjie
    Jin, Keyi
    Zheng, Yan
    Zhu, Xiaoqiong
    Chen, Dan
    Jin, Jie
    Huang, Jian
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (06) : 2383 - 2392
  • [4] Easily Applicable Predictive Score for Differential Diagnosis of Prefibrotic Primary Myelofibrosis from Essential Thrombocythemia
    Lekovic, Danijela
    Bogdanovic, Andrija
    Sobas, Marta
    Arsenovic, Isidora
    Smiljanic, Mihailo
    Ivanovic, Jelena
    Bodrozic, Jelena
    Cokic, Vladan
    Milic, Natasa
    CANCERS, 2023, 15 (16)
  • [5] Primary myelofibrosis: rs2010963 VEGFA polymorphism favors a prefibrotic phenotype and is associated with higher risk of thrombosis
    Villani, Laura
    Rosti, Vittorio
    Massa, Margherita
    Campanelli, Rita
    Catarsi, Paolo
    Carolei, Adriana
    Abba, Carlotta
    De Silvestri, Annalisa
    Gale, Robert Peter
    Barosi, Giovanni
    LEUKEMIA RESEARCH, 2021, 111
  • [6] Prognostic impact of splenomegaly on survival of Chinese with primary myelofibrosis
    Wang, Jingya
    Xu, Junqing
    Gale, Robert Peter
    Xu, Zefeng
    Li, Bing
    Qin, Tiejun
    Zhang, Yue
    Fang, Liwei
    Zhang, Hongli
    Pan, Lijuan
    Qu, Shiqiang
    Zhang, Peihong
    Xiao, Zhijian
    LEUKEMIA RESEARCH, 2014, 38 (10) : 1207 - 1211
  • [7] Practical application and clinical impact of the WHO histopathological criteria on bone marrow biopsy for the diagnosis of essential thrombocythemia versus prefibrotic primary myelofibrosis
    Brousseau, Maud
    Parot-Schinkel, Elsa
    Moles, Marie-Pierre
    Boyer, Francoise
    Hunault, Mathilde
    Rousselet, Marie-Christine
    HISTOPATHOLOGY, 2010, 56 (06) : 758 - 767
  • [8] Impact of 2016 WHO diagnosis of early and overt primary myelofibrosis on presentation and outcome of 232 patients treated with ruxolitinib
    Palandri, Francesca
    Palumbo, Giuseppe A.
    Abruzzese, Elisabetta
    Iurlo, Alessandra
    Polverelli, Nicola
    Elli, Elena
    Bonifacio, Massimiliano
    Bergamaschi, Micaela
    Martino, Bruno
    Tiribelli, Mario
    Benevolo, Giulia
    Tieghi, Alessia
    Sgherza, Nicola
    Isidori, Alessandro
    Binotto, Gianni
    Crugnola, Monica
    Heidel, Florian
    Cavazzini, Francesco
    Bosi, Costanza
    Auteri, Giuseppe
    Cattaneo, Daniele
    Foa, Robin
    Lemoli, Roberto M.
    Cuneo, Antonio
    Krampera, Mauro
    Bartoletti, Daniela
    Cavo, Michele
    Vianelli, Nicola
    Breccia, Massimo
    Latagliata, Roberto
    HEMATOLOGICAL ONCOLOGY, 2019, 37 (04) : 418 - 423
  • [9] Sex and degree of severity influence the prognostic impact of anemia in primary myelofibrosis: analysis based on 1109 consecutive patients
    Nicolosi, Maura
    Mudireddy, Mythri
    Lasho, Terra L.
    Hanson, Curtis A.
    Ketterling, Rhett P.
    Gangat, Naseema
    Pardanani, Animesh
    Tefferi, Ayalew
    LEUKEMIA, 2018, 32 (05) : 1254 - 1258
  • [10] Cytomegalovirus infection induces a stem cell phenotype in human primary glioblastoma cells: prognostic significance and biological impact
    Fornara, O.
    Bartek, J., Jr.
    Rahbar, A.
    Odeberg, J.
    Khan, Z.
    Peredo, I.
    Hamerlik, P.
    Bartek, J.
    Stragliotto, G.
    Landazuri, N.
    Soderberg-Naucler, C.
    CELL DEATH AND DIFFERENTIATION, 2016, 23 (02) : 261 - 269
12